Ka-Wai WanSenior Pharmaceutical Assessor at MHRA (Medicines and Healthcare products Regulatory Agency)
Dr Ka-Wai Wan is a pharmacist by training and graduated from The School of Pharmacy (University of London). She was trained as a hospital pharmacist before completing her PhD in nanomedicine at the Welsh School of Pharmacy (Cardiff, UK). Ka-Wai worked as an academic for over a decade and she was a Principal Lecturer in Pharmaceutics and Course Leader for the MSc Industrial Pharmaceutics from the School of Pharmacy and Biomedical Sciences at the University of Central Lancashire (UCLan, Preston) before moving to work at the Medicines and Healthcare products Regulatory Agency (MHRA) in 2016. She is now a Senior Pharmaceutical Assessor at the MHRA, leading on the assessment of nano-based medicinal products, and providing scientific advice on innovative medicines, particularly on nanomaterials used for both small and macromolecules delivery. Her past research experience lie in the field of nano-based drug delivery systems (polymers, liposomes and lipid nanoparticles) for targeted therapy and delivery of macromolecules such as nucleotides and proteins, particularly for cancer and anti-infective applications.
All Sessions by Dr. Ka-Wai Wan
Title: Regulatory considerations for nanomedicines
- The evolution of nanomedicines and the accelerated development of LNPs
- Overview of the regulatory pathways and scientific support available for mRNA-LNP applications in the UK
- A science-based approach towards regulation of LNP-based medicinal products for human use.